The quantitative contribution of these and other forms of cell death to ALT elevations in chronic hepatitis B are unknown, and it remains a concern that ALT measurements may fail to detect the mild hepatitis that has been observed histologically in IT patients [6,7] and could be contributing to disease progression during the IT phase. This evidence concerns the gene GPT and hepatitis A virus infection.